Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What are the infringers thinking now?

"Also I beleive that if there are firm payments from the J's forthcoming, this would be reflected in the 10Q in some fashion (e.g., accounts receivable).  After all, such a thing would be considered an asset, and couldn't just be ignored/withheld IMO".

SGE, I hope you are correct, this has been one of my biggest fears is that the 10Q in April may not tell us what the J's payment plan (i.e. one lump, quarterly or annual) might be and if the Q shows $30M or less with no guidance that the SP will spiral down again.

All the best,

Steve

Share
New Message
Please login to post a reply